Rho Ventures is a private equity firm that invests in high growth companies across multiple sectors.
Business Model:
Revenue: $39.7M
Employees: 201-500
Address: 152 W 57th St
City: New York
State: NY
Zip: 10019
Country: US
We invest across most high growth sectors of today’s economy and have developed deep expertise and relationships in Information Technology, Communications, New Media, Healthcare and New Energy. Since 1981, Rho Ventures has been investing in innovators that redefine the status quo. Rho’s investment philosophy does not fit a conventional model, much like the visionary innovators we back. We believe that formulaic approaches to investing lead to risk averse strategies that stifle innovation and differentiation. We actively avoid restrictive boundaries around ideas, growth opportunities and entrepreneur profiles. To find extraordinary opportunities, we are not bound by a particular stage of investment and do not shy away from contrarian ideas. We believe that great companies take root in unconventional places and that successful entrepreneurs frequently break the mold. The ideas we back come from a variety of sources: an MBA student who is trying to change new media advertising practices; an experienced entrepreneur seeking to commercialize a disruptive biofuels technology; or an executive looking to spin out and develop an abandoned asset developed by a pharmaceutical company. We are seasoned investors who have backed more than 200 companies through multiple cycles. Identifying interesting opportunities and providing capital is just the beginning. We offer deep-sector expertise in today’s high-growth markets, but we do not let any one area of knowledge guide our overall investment strategy. Ultimately, we look for entrepreneurs who we can help make very big waves, not just stir the waters and move on to the next venture.
Contact Phone:
+12127516677
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2021 | TrialJectory | Series A | 0 |
7/2001 | PHT Corporation | Series D | - |
4/2019 | Enerkem | Corporate Round | 0 |
11/2018 | Plotly | Series B | 0 |
8/2000 | Alien Technology | Venture Round | 0 |
6/2015 | Philo | Series B | 0 |
5/2013 | Convey Computer | Private Equity Round | 0 |
3/2014 | SolarBridge Technologies | Series E | 0 |
5/2004 | ON24 | Venture Round | 3.3M |
2/2004 | LightPointe | Venture Round | 17M |
7/2002 | InnerWireless | Venture Round | 0 |
4/1999 | Applied Science Fiction | Venture Round | 31.5M |
9/2000 | Senomyx | Series B | 10M |
10/2006 | Tolerx | Series D | 61M |
3/2005 | Tolerx | Series D | 31M |
11/2001 | OraMetrix | Series C | 25M |
9/2000 | Chiaro Networks | Series C | 100M |
3/2005 | Netifice Communications | Venture Round | 55M |
10/2006 | Ripe Digital Entertainment | Series B | 0 |
11/2004 | BroadLogic Network Technologies | Series C | 20M |
11/1999 | PHT Corporation | Series B | 0 |
11/2013 | August Home | Series A | 8M |
7/2007 | NowPublic | Series A | 10.6M |
1/2012 | AdaptiveBlue | Series D | 12M |
6/2003 | Orqis Medical | Series C | 25M |
4/2014 | Nora Therapeutics | Series B | 18M |
3/1999 | OraMetrix | Series A | - |
12/2008 | Patersons HR and Payroll Solutions | Series A | 30k |
2/2008 | Advancis Pharmaceutical | Post-IPO Equity | 21M |
4/2004 | Inotek Pharmaceuticals | Series A | 20M |
2/2010 | ChargePoint | Series B | 14M |
4/2004 | Archemix | Series B | 50M |
2/2010 | Narratiive | Series A | 4M |
8/2007 | Inotek Pharmaceuticals | Series C | 19.3M |
6/2001 | Orqis Medical | Series B | 5.2M |
7/2011 | Tapjoy | Series D | 30M |
1/2023 | Aluna | Series B | 0 |
12/2015 | Vidyo | Series E | 15M |
5/2018 | Wunderkind (formerly BounceX) | Series B | 0 |
9/2020 | Suzy | Series C | 16M |
7/2005 | BrightVolt | Series C | 15M |
7/2013 | Mandalay Sports Media | Private Equity Round | - |
6/2015 | Plotly | Series A | 5.5M |
2/2001 | Intralinks | Venture Round | 0 |
5/2012 | ChargePoint | Series D | 47.5M |
1/2011 | Vidyo | Series C | 0 |
1/2003 | Tolerx | Series C | 35M |
12/2012 | CloudPay | Series B | 16M |
2/2022 | TrialJectory | Series A | 0 |
7/2011 | Clean Urban Energy | Series A | 7M |
10/2008 | Alien Technology | Venture Round | 38M |
9/2013 | TechStyle Fashion Group | Series C | 55M |
1/2013 | Innova Dynamics | Series B | - |
1/2012 | Playerize | Series A | 0 |
1/2008 | Nuventix | Series A | 8.5M |
10/2003 | PHT Corporation | Series E | 5M |
4/2013 | Lagoa | Seed Round | 1.6M |
7/2002 | Anacor Pharmaceutical | Series A | 2.9M |
11/1999 | TechSmart.com | Series A | 13M |
5/2012 | SolarBridge Technologies | Series D | 25M |
6/2004 | Mahi Networks | Venture Round | 70.1M |
2/2002 | Chiaro Networks | Series D | 80M |
3/2010 | Makeover Solutions | Venture Round | 1M |
7/2012 | Mersana Therapeutics | Series A | 27M |
1/2012 | GetGlue | Venture Round | 12M |
11/2005 | Inotek Pharmaceuticals | Series B | 35M |
9/2013 | Inotek Pharmaceuticals | Debt Financing | 0 |
6/2000 | New World Communications | Venture Round | 150M |
6/2011 | Fixmo Carrier Services | Series B | 6.5M |
10/2008 | Everyday Health Group | Series F | 22.5M |
4/2006 | Amp&s;d Mobile | Venture Round | 7.5M |
6/2013 | Enerkem | Private Equity Round | 48.4M |
7/2013 | Philo | Series A | 0 |
9/2007 | Everyday Health Group | Series D | 25M |
7/2003 | Tercica | Series B | 44M |
7/2013 | NGM Biopharmaceuticals | Series C | 50M |
5/2014 | ChargePoint | Series E | 27M |
10/2001 | D Pharm LTD. | Series D | 0 |
9/2013 | Inotek Pharmaceuticals | Venture Round | 0 |
2/2000 | MainControl | Venture Round | 18M |
9/2013 | Keaton Row | Seed Round | 1.6M |
4/2003 | Ipsum Networks | Series B | 6M |
1/2016 | Tapjoy | Series E | 15M |
11/2006 | Alien Technology | Venture Round | 50M |
9/2002 | CarParts | Series D | 0 |
6/2002 | Sionex | Series A | 0 |
3/2007 | Orqis Medical | Series D | 12M |
2/2014 | inPowered | Seed Round | - |
4/2005 | Diagnostic Ultrasound | Venture Round | 34M |
7/2002 | Ample Communications | Series B | 21M |
1/2010 | Innova Dynamics | Series A | - |
4/2009 | Nuventix | Series C | 0 |
12/2005 | Verified Person | Series C | 12M |
10/2001 | Tolerx | Series B | 17M |
6/2014 | Nuventix | Debt Financing | 0 |
12/2009 | NGM Biopharmaceuticals | Series A | 26.6M |
4/2013 | Vidyo | Series D | 17.1M |
1/2016 | Confirm | Seed Round | 0 |
9/2012 | Dashlane | Series A | 3M |
1/2014 | AqueSys | Series D | 43.6M |
7/2007 | Verified Person | Series D | 5.4M |
7/2008 | OraMetrix | Series C | 0 |
11/2002 | Anacor Pharmaceutical | Venture Round | 4M |
1/2000 | Quintessent Communications | Series C | 15M |
5/2019 | Dashlane | Series D | 110M |
10/2004 | Gloucester Pharmaceuticals | Series B | 29M |
1/2013 | True Office Learning | Series A | 3M |
10/2004 | Verified Person | Series B | 2M |
11/2003 | Sionex | Series B | 12.8M |
5/2001 | Human Genome Sciences | Venture Round | - |
12/2019 | Vertoe | Convertible Note | 2M |
5/2011 | Everyday Health Group | Series G | 5M |
6/2001 | NitroMed | Series E | 0 |
7/2014 | Vidyo | Series E | 20M |
12/2008 | CloudPay | Series A | 30M |
12/2022 | Blocknative | Series A | 0 |
7/2006 | Tello | Series B | 10M |
2/2004 | Ample Communications | Series C | 15M |
5/2014 | Dashlane | Series B | 21.8M |
2/2013 | Savelli | Series B | 4M |
10/2010 | Travora Networks | Series C | 15M |
1/2006 | Tello | Venture Round | 5.5M |
3/2021 | Feel | Seed Round | 4M |
5/2016 | Dashlane | Series C | 22.5M |
12/2017 | Convercent | Series E | 0 |
5/2018 | CloudPay | Equity | 25M |
8/2003 | Xtera | Venture Round | 0 |
1/2007 | Enerkem | Venture Round | 8.6M |
2/2022 | TrialJectory | Series A | 0 |
3/2021 | Feel | Seed Round | 0 |
2/2021 | TrialJectory | Series A | 0 |
12/2019 | Vertoe | Convertible Note | 0 |
5/2019 | Dashlane | Series D | 0 |
4/2019 | Enerkem | Corporate Round | 0 |
11/2018 | Plotly | Series B | 0 |
5/2018 | Wunderkind (formerly BounceX) | Series B | 0 |
5/2018 | CloudPay | Series C | 0 |
12/2017 | Convercent | Series E | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|